Schedule 13G ownership disclosure

ELEVATION ONCOLOGY INC

Common Stock, par value $0.0001 per share · CUSIP: 28623U101

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • TANG CAPITAL MANAGEMENT, LLC

    Shares: 6,043,921.00 · Class: 9.99%

  • KEVIN TANG

    Shares: 6,043,921.00 · Class: 9.99%

  • TANG CAPITAL PARTNERS, LP

    Shares: 5,052,545.00 · Class: 8.35%

  • TANG CAPITAL PARTNERS INTERNATIONAL, LP

    Shares: 551,376.00 · Class: 0.91%

  • TANG CAPITAL PARTNERS III, INC

    Shares: 440,000.00 · Class: 0.73%

  • TANG CAPITAL PARTNERS IV, INC

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001214659-25-007873
Form type
SCHEDULE 13G/A
Filer
Elevation Oncology, Inc.
CIK
CIK 1783032
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub